8-KThe WireRoutine
Bylaw Amendment
Filed Jun 30, 2022 · 4y ago · Accession 0001193125-22-186293
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Definium Therapeutics, Inc.
- Ticker
- DFTX
- CIK
- 1813814
- Form type
- 8-K
- Filing date
- Jun 30, 2022
- Report date
- Jun 30, 2022
- Document
- d730734d8k.htm
- Size
- 696 KB